TE-array—a high throughput tool to study transposon transcription
© Gnanakkan et al.; licensee BioMed Central Ltd. 2013
Received: 14 March 2013
Accepted: 27 November 2013
Published: 10 December 2013
Although transposable element (TE) derived DNA accounts for more than half of mammalian genomes and initiates a significant proportion of RNA transcripts, high throughput methods are rarely leveraged specifically to detect expression from interspersed repeats.
To characterize the contribution of transposons to mammalian transcriptomes, we developed a custom microarray platform with probes covering known human and mouse transposons in both sense and antisense orientations. We termed this platform the “TE-array” and profiled TE repeat expression in a panel of normal mouse tissues. Validation with nanoString® and RNAseq technologies demonstrated that TE-array is an effective method. Our data show that TE transcription occurs preferentially from the sense strand and is regulated in highly tissue-specific patterns.
Our results are consistent with the hypothesis that transposon RNAs frequently originate within genomic TE units and do not primarily accumulate as a consequence of random ‘read-through’ from gene promoters. Moreover, we find TE expression is highly dependent on the tissue context. This suggests that TE expression may be related to tissue-specific chromatin states or cellular phenotypes. We anticipate that TE-array will provide a scalable method to characterize transposable element RNAs.
KeywordsMobile DNA Expression microarray L1 LINE Endogenous retrovirus SINE
What fraction of mammalian genomes is transcribed has been the subject of intense debate in the scientific literature as different genome-scale platforms have availed themselves to the question [1–6]. In analyzing the transcriptome, non-coding RNAs and products from interspersed genomic repeats have lagged in their characterization as compared to annotated genes. The latter highly repetitive sequences are copies of transposable elements (TEs). Though often dismissed as ‘junk DNA’, cap-selected RNA analyses have suggested that substantial portions of mammalian transcripts originate within these sequences , and so they may play significant roles in shaping the functional transcriptome.
Hosts have evolved several lines of defense to curb the activity of transposons, including barriers to transcription and means to process transposon-encoded RNAs, though their effectiveness in curbing expression of specific TEs in different contexts are not well described. There are several reasons for researchers to survey TE expression. These include better characterizing pathologic states. For example, massive TE derepression is thought to be cytotoxic, and is associated with male germ cell loss in experimental models and retinal epithelium damage in macular degeneration in humans (reviewed in  and ). Effects of repeat expression on perhaps a smaller scale may play roles in other diseases - for example, promoting genomic instability in tumors [15–17]. Additionally, derepression of TEs in tumors can generate tumor specific antigens and chimeric transcripts with oncogenic or tumor suppressor activities. Thus, TE-encoded RNAs and proteins may have utility as diagnostic or prognostic markers or as targets for therapy, independent of the ability of the associated TE to promote its own transposition [18–21].
To describe transposon expression in a variety of normal and diseased states, we developed a custom microarray, which we term TE-array. Traditional gene expression microarrays have proved capable of identifying altered TE expression [22–24], but most do not systematically survey numerous types of TEs. We developed platforms tiling all mouse and human TE sequences in both sense and antisense strands. The approach has the advantages of being fairly comprehensive and easily scaled with costs and turn-around times comparing favorably with RNAseq. We envision TE-array as an efficient modality for screening mouse phenotypes and human disease states for changes in patterns of TE expression.
Results and discussion
Design of TE-array
To varying degrees, most gene expression microarrays and genomic tiling arrays used for chromatin immunoprecipitation (ChIP-chip) studies ‘mask’ repeat sequences from consideration in probe design or exclude probes without unique matches to the reference genome. Rationales for this include concern that these probes will not behave technically like unique sequence probes (i.e., they will be a source of non-specific high signal) and that they will fail to provide desired information reflective of a specific gene or genomic locus. We are interested in studying transposon-derived sequences, and so we designed an array in which these repetitive probes are the main features.
We designed TE-array probes using annotated consensus sequences of Mus musculus or Homo sapiens specific repeats from Repbase [11, 12]. Probes were obtained using a custom PERL script to collect 60 bp sequences across the length of each repeat consensus. Overlapping probes were collected with offsets of 14-15 bp increments over short repeats, and every 30-45 bp for long repeats. For the sense strand arrays, the probes are the same strand (i.e., the identical sequence) as the consensus sequence found in Repbase [11, 12]. We also created counterpart arrays for antisense strand detection by using the reverse complement of each probe sequence. We did not duplicate highly similar probe sequences, culling probes from the list with fewer than 3 bp mismatches to an already accepted probe using BOWTIE and un-gapped BLAST alignments. The contribution of different TE families to total genomic repeat content for the two species is shown (Figure 1A). The representation of each family with respect to probes on TE-array mirrors these proportions (Figure 1B). For all of the experiments described, we prepared labeled RNA samples for hybridization to TE-array in accordance with standard methods for gene expression arrays. A schematic of both TE-array design and RNA sample labeling is shown in Additional file 1: Figure S1.
To test the reproducibility of TE sequence probe behavior, we carried out a series of technical and biological replicates. Technical replicates involved multiple hybridizations of single RNA preparations. We used RNA from breast cancer cell lines derived from Balbc mice overexpressing rat Her2/Neu for these studies, N3D and N1G. Briefly, adherent cells were expanded, total RNA extracted, cDNA labeled in parallel Cy3-dCTP and Cy5-dCTP reactions, and sense strand TE-arrays hybridized for 17 hours. Variability in dye behaviors was normalized using the widely applied local regression (LOESS) method [25–27]. The M value, defined as the log2 ratio of the normalized Cy3 and Cy5 fluorescent intensities, was evaluated at each probe. As expected, the M values from technical replicate comparisons scatter at M value = 0 (median M value = 0.00; s.d. = 0.21 for N1G). Additional file 2: Figures S2A and B show the pairwise correlation plots within each replicate type and cell line.
Two types of biological replicates were performed; the first compared different RNA preparations from independent cultures of the same cell line. In these studies, we labeled one RNA sample using Cy3 and its corresponding sample using Cy5; and hybridized these together (Additional file 2: Figure S2C and D; M value s.d. = 0.33 and 0.47, respectively). The second approach used RNA isolated from different dissections of the same mouse organ compared to RNA from a pool of different mouse organs; results of these studies are described further below. Additional file 3: Table S1 describes the number of replicates used in each phase of this study.
Detection of expressed genes and transfected transposons
We included gene-specific probes on the microarray as positive controls for reverse transcription and hybridization conditions. As expected, these probes showed previously described patterns of gene expression. Tissue specific expression was most striking for several testis genes (Additional file 4: Figure S3).
As a positive control for TE expression detection, we transfected human HeLa cells with a plasmid to exogenously express Long INterspersed Element 1 (LINE-1 or L1). L1 sequences account for about 17% of the human genome, and L1 is of special interest as a subset are active today in humans and mice [28–31]. There are an estimated 500,000 copies of L1 in the human genome, although most are small fragments. Endogenous L1 transcripts and splice products have been reported as a series of faint bands in Northern blots of HeLa cells using a 5′UTR L1 probe .
To better understand why a subset of L1Hs probes showed changes in expression in this experiment, we plotted the M value of each probe verses its copy number in genomic DNA (Figure 2B). Full length (6 kb) L1 genomic copies are infrequent, and most are 5′ truncated. This observation has been ascribed to interruptions in the reverse transcription (RT) and integration of new L1 sequences; RT initiates at the 3′ L1 end . Thus, the 3′ L1 end is present in several hundred thousand genomic copies, whereas the 5′ end occurs a few thousand times in our genome (probes mapping to regions 750 bp and upstream of an L1 human specific (L1Hs) element average at 6774 copies in the human genome) (Figure 2B, black line). We saw the highest M value increments with L1 expression selectively at 5′ L1 probes (Figure 2B, red line). The effect was pronounced; probes mapping to the 3′ end were not significantly different in the cells transfected with L1 as compared to control GFP-transfected cells. Since many of the latter probes showed high fluorescence intensity in both transfected and untransfected samples, we propose that these probes reflect chimeric transcripts or non-specific ‘read through’ RNAs that incorporate the 3′ end of L1. A schematic of these presumptive products (present in L1-transfected and control cells) and the relatively greater increase in 5′ L1 RNA sequences with transfection is shown (Figure 2C).
TE-array ‘top hits’ show concordance with nanoString®and RNAseq analyses
(i) nanoString ® concordance
NanoString is an RNA quantification method based on the ability of RNA molecules to bridge complementary, sequence-specific ‘capture’ and ‘reporter’ probes .
(ii) RNAseq concordance
The same 30 TE regions were also evaluated using publicly available RNAseq data . TE aligning read counts were acquired using sequencing of polyadenylated RNA from individual tissues as well as an in silico generated RNA pool. The log2 ratios of read counts were compared to TE-array M values. The average Pearson’s correlation coefficients between all tissue comparisons is 0.81; data are shown in Figure 3B.
Strand bias in TE RNA levels
Antisense specific TE arrays have special utility to reveal transcription initiated from internal TE antisense promoters as well as instances of repeat-containing transcripts generated by ‘read-through’ transcription with TE ‘exonization’, which can happen in either direction along the length of a repeat unit. In some cases, internal TE antisense promoters (ASP) are known and may be expected to reproducibly generate signal at corresponding probes. An example is an ASP in the 5′ end of human L1s . Exonization events, in which an intronic or gene proximal TE is expressed by ‘read through’ and retention of TE sequence in a cellular transcript would map in a highly locus-dependent manner, with intervals of expression bounded by any functional splice sites along the length of the TE.
Similarly, most instances of differential (tissue-specific) TE expression were seen in the sense orientation. An example expression plot shows this (Figure 4B). Here, distinct portions of the IAPEY4_I endogenous retrovirus consensus sequence can be seen to be expressed in heart. This is unique to the sense strand (top panel, slate blue line) and not evident when the antisense strand is considered (lower panel). The M value (log2 ratio) is used as the metric for differential expression in this plot.
M values for more TEs are represented by red/green color intensities for sense and antisense detecting arrays (Figure 4C). Of the tissues studied, testis showed relatively more expression of antisense TE transcripts as compared to somatic tissues, an effect we consider further in the discussion.
TE transcripts show tissue-specific expression patterns
To investigate how expression patterns vary with tissue type, we profiled sense TE expression in a panel of normal mouse tissues, including lung, heart, liver, kidney, brain, breast, and testis.
Finally, we tested whether TE sequences may be expressed in a tissue-specific manner because of co-regulation with surrounding tissue-specific genes. Disproportionate numbers of these TE sequences embedded in differentially expressed gene loci would be an indication of such co-regulation. To assess this, we recovered genomic positions corresponding to differentially expressed TE segments and annotated each for occurrence within a gene transcript unit. For a given tissue type, this provided a list of gene loci containing sequences of differentially expressed TEs. We saw no overrepresentation of differentially expressed genes as compared to randomly selected genes in these lists (data not shown).
Measuring expression from highly repetitive genomic sequences is complex. Part of this is owed to inherent features of genomic repeats. Many TE families have populated mammalian genomes over evolutionary time, and members of each type have shown fragmentation and degenerating homology with aging. A second layer of complexity stems from variant transcript structures. Interspersed repeat sequences can be transcribed actively as well as passively as a part of a cellular pre-mRNA or other forms of cellular RNA, and can then be processed by RNA splicing machinery with a variety of outcomes . Thus, though methods like Northern blots , RNase protection assays , RT-PCRs , and RACE PCRs  all suggest interesting patterns of repeat expression in human tissues and cells, they thus far have focused on a very minor subset of elements (often, those competent for transposition). They cannot be practicably scaled to capture the complexity of the ‘mobilome’ in a variety of tissue types.
We thus approached the task of designing a TE expression microarray platform. For both human and mouse repeats, we have designed an 88,000 probe, two array set that is available for distribution to laboratories through the manufacturer. Probes have been designed against all annotated transposons - approximately 300 mouse and 500 human TE consensus sequences - in both sense and antisense orientations. Coverage is dense and deep (~10X on average), with probes sequences designed in overlapping intervals along the length of each TE consensus sequence. We address numerous technical concerns in this publication, showing that these probes do not generate arbitrary irreproducible signals and that there is agreement between TE-array and other state-of-the-art RNA detection modalities, including nanoString and RNA-seq.
Using TE-Array to profile transposon expression in a variety of normal mouse tissues, we make two encompassing observations. The first is that transposon expression is detectable most frequently from probes for sense strand transcripts. This expression is most often segmental or involving short series of contiguous probes along the length of longer repeat sequences. We interpret the strand bias as evidence that sequences intrinsic to the interspersed repeats themselves are directing much of this transcription, consistent with the observation that many transcripts originate in this portion of the genome . In contrast, exclusively ‘read through’ transcription of intronic TEs as directed by gene promoters would be expected to give comparable signals in sense and antisense for most element types where there is random orientation of each TE within its gene locus.
Our second major observation is that there are highly distinct patterns of retroelement expression in crosswise comparisons of different mouse tissues. Specific intervals of a broad complement of TE families appear differentially expressed in any given tissue. These patterns of sense strand repeat expression appear pervasive; they do not only typify testis, where specific TE repression pathways have been described or brain, where L1 LINE expression has been studied (reviewed in ). Interestingly, although testicular samples adhere to the sense strand bias we describe above, examples of intense signals from antisense probes are more prevalent in this tissue. It is possible these signals reflect primary antisense transcripts from TEs or piRNA clusters which initiate piRNA biogenesis . piRNAs in turn are critical for imposing TE silencing during gametogenesis. Spermatogenic tubule dissection experiments may demonstrate stage specificity for these antisense species and provide insights into their regulation.
Our work complements and extends observations made with the first generation of microarrays to detect interspersed repeats, RepArray, designed by Horard et al. . Using 236 oligonucleotides, their design designates a single oligonucleotide target and its reverse complement for each type of transposable element. Each probe appears in duplicate on the array. The key advantage of our platform design relates to probe quantity; TE-array comprises in contrast 88,000 probes. A ten kilobase retrovirus is given a single sense-oriented and antisense-oriented probe pair on RepArray chosen to maximize specificity for that family. The same element is represented by more than 650 overlapping, sense and antisense oriented probes on TE-array. Given how TE expression can be seen over discrete intervals within a larger consensus sequence, this density of coverage appears vital to capture. Excitingly, RepArray has proven useful not only as an expression array, but also in transcription factor chromatin immunoprecipitation (ChIP) and methylated DNA immunoprecipitation (MeDIP) experiments . Although these applications may be highly sensitive to the lack of probe coverage on this platform, the experiments are a demonstration of how microarrays can give insights into TE regulation at multiple molecular levels.
Our discovery of regulated, differential TE expression in tissues – from sequences incapable of transposition and in somatic cells where there is no consequence for TE propagation in the population – might be viewed as an unexpected result from the perspective of transposon biology. Whether these are ‘exapted’ elements with functional roles in tissues is unknown, though their discovery begins to make this question experimentally tractable. Moreover, outside of normal cell differentiation and function, profiling TE expression in cancers, infertilities, and degenerative conditions where repeat derepression has been described may suggest functional roles in disease or provide new markers of a disease state.
In summary, we show that a wide diversity of transposon sequences can be incorporated in expression microarray designs to provide more comprehensive profiles of TE expression. First applications of the technology suggest that control of TE expression is determined by repeat encoded sequence features and regulated in a highly tissue-specific manner.
RNA extraction from cell lines and tissues
Normal tissue experiments used 12 week old C57BL/6 mice. Animals were sacrificed. The tissues were dissected and flash frozen on dry ice. Tissue subsections were homogenized in Trizol (Invitrogen, Carlsbad, CA) and total RNA was extracted and ethanol precipitated (Ambion, Carlsbad, CA). RNA was quantified using Nanodrop (Thermo Fisher Scientific, Wilmington, DE) and its integrity measured using Bioanalyzer 2100 (Agilent, Santa Clara, CA) according to the manufacturer’s directions. Normal somatic tissue RNA pools of 6 μg were made by combining 600 ng of RNA from each of the following tissues: lung (2 male animals, 300 ng each and 1 female animal, 600 ng), brain (3 males, 200 ng each and 3 females 200 ng each), liver (1 male, 600 ng and 1 female, 600 ng), kidney (1 male, 600 ng and 1 female, 600 ng) and heart (1 male, 600 ng and 1 female, 600 ng).
Cell line experiments used human HeLa (subclone HA) and mouse N1G, N2C and N3D, all three of which were derived from primary breast cancer overexpressing Rat Her2/Neu in Balbc mice .
L1HS transfection and qRT-PCR
HeLa-HA cells were maintained in Dulbecco’s Modified Eagle Medium (D-MEM) supplemented with 10% fetal bovine serum and 100units/ml penicillin/streptomycin. HeLa were seeded in 6-well plates (2×105 cells/well) the day before transfection. pLD107 (pCEP puro -eGFP) was made by cloning eGFP gene into pCEP puro plasmid after the CMV promoter (between NheI and BamHI sites). pLD190 (pCEP puro L1.3-GFPAI) was made by replacing L1RP sequence (NotI/BstZ17I fragment) within pLD223  with L1.3 fragment from JM101 (Not I/BstZ17I) . The next day each well was transfected with 1 μg of either pLD107 or pLD190 plasmid using Fugene 6 (Roche Applied Science, Indianapolis, IN) according to the manufacturer’s protocol. The day after transfection, cells were trypsinized and transferred to a 6 cm plate with 4 mL DMEM medium containing puromycin (2.5 μg/ml). After 3 days of puromycin selection, total RNA was extracted using RNeasy mini kit (Qiagen, Valencia, CA) according to the manufacturer’s protocol. For qRT-PCR, 1 μg RNA was used for cDNA synthesis using Superscript® III reverse transcription kit (Invitrogen, Carlsbad, CA) in a 20 μL reaction. Real time PCR was performed using a 1 μl cDNA sample as template in a 20 μL reaction on a Step One Plus instrument (Applied Biosystems, Carlsbad, CA). Primers used for real time PCR were: Beta actin gene: JB12931, JB12932; L1: JB14148, JB14149, JB14150. The 2-DDCT method was used for normalization to the β-actin mRNA level.
Microarray probe design
Agilent Microarray Design Identifiers for TE-arrays
Agilent Microarray Design Identifier (AMADID)
RNA labeling and microarray hybridization
Poly-A RNA was reverse transcribed to double stranded cDNA using MMLV RT. T7 promoter was ligated to the 3′ end corresponding to poly-A. T7 was used to generate single stranded, labeled cRNA. RNA was labeled using Quick amp kit (Agilent) with Cy-dye labeled Cytosine. Arrays were hybridized following the manufacturer’s protocol for 17 h. Longer hybridization times up to 65 h were attempted in order to verify saturation at the recommended 17 h. Arrays were washed and scanned on an Agilent 2 μm scanner at 70% PMT (photomultiplier tubes) for both green and red channels.
Microarray data analysis
Fluorescence signals were preprocessed and normalized using the limma software package from R/Bioconductor . Specifically, probe intensities from the two-channel arrays were log2 transformed and LOESS normalized. Raw intensity plots suggested high hybridization efficiency (not shown). Subsequent analyses were performed on the normalized log2 fold changes of each probe/transposable element relative to a control channel (M value). This can be considered a measure of relative expression abundance. For example, M = 1 for a given tissue and repeat family corresponds with that family having twice as much expression in the experimental sample (i.e., RNA of a specific tissue or cells with L1 expression) as compared to a reference sample (i.e., RNA of a multi-tissue pool or cells after a control transfection).
We performed “bumphunting” algorithm, adapted from microarray-based DNA methylation data [49, 50], to identify transposon families showing expression. First, M values were smoothed within each family using LOESS, a smoothing function robust to outliers , with a smoothing window of approximately 100 base pairs - this within-family smoothing was performed for each family. An F-statistic was computed at each probe from the smoothed M values to identify differential expression by tissue type (statistical model: M ijk = α i + ∑ k β ik X jk + ϵ ijk for probe i, biological replicate j, and tissue type k where X is an indicator for tissue type, compared to the intercept only model: M ij = α i + ϵ ij ). Then we performed thresholding to identify contiguous probes within a given transposable element family that were differentially expressed by tissue type. We therefore identify differentially expression regions from differentially expressed probes – each region was summarized by the sum of its F-statistics within the region (an “area” statistic) and ranked by this area.
Cross platform comparisons
We compared the “top hits” called by TE-Array using nanoString (nanoString technologies, Seattle, WA) and publicly available RNA sequencing (RNAseq) data.
(i) nanoString comparison
A non-redundant subset of 30 “top hit” regions (>200 bp long) was selected along with positive control regions from 3 housekeeping genes (Oaz1, Rpl27 and Rps13). These sequences were submitted to nanoString for probe design as per the company’s protocols. The probes and 200 ng of RNA from 11 tissues and the pool of somatic tissue RNA were run on the nCounter. Discrete transcript counts from individual tissues and the somatic tissue pool were obtained. Log2 ratios comparing individual tissues to the somatic pool were determined and compared to the corresponding TE-array M values.
(ii) RNAseq comparison
Previously described  RNAseq data were chosen to match the genetic background and approximate age of mice used in our experiments. We used RNAseq data from testis and male and female brain, lung, liver, kidney and heart. Tissue specific reads were aligned to extracted segments of TE consensus sequences corresponding to the “top hit” interval using Bowtie  allowing for at most 3 mismatches. For comparison, we generated an in silico pool of somatic tissue (male and female brain, lung, liver, kidney and heart) RNA reads by averaging aligned read counts of the included tissues, and calculated log2 ratios of each individual tissue alignable read count to this average. This was compared to the corresponding M value from TE-Array and the Pearson’s coefficient of correlation was calculated.
The data discussed in this publication have been deposited in NCBI’s Gene Expression Omnibus and are accessible through GEO Series accession number GSE52412 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE52412).
We thank Rafael Irizarry for invaluable discussions in the development of this work, and we thank Peilin Shen for technical assistance. Work in the Burns laboratory is supported by NIH awards R01GM103999 and R01CA163705, DOD award OC120390, and a Career Award for Medical Scientists from the Burroughs Wellcome Foundation. This work was also supported by NIH awards P01CA16519 and RC1HG005359 to JDB.
- Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, et al: The transcriptional landscape of the mammalian genome. Science. 2005, 309 (5740): 1559-1563.View ArticlePubMed
- Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, Thurman RE, et al: Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 2007, 447 (7146): 799-816. 10.1038/nature05874.View ArticlePubMed
- Johnson JM, Edwards S, Shoemaker D, Schadt EE: Dark matter in the genome: evidence of widespread transcription detected by microarray tiling experiments. Trends Genet. 2005, 21 (2): 93-102. 10.1016/j.tig.2004.12.009.View ArticlePubMed
- Kapranov P, Willingham AT, Gingeras TR: Genome-wide transcription and the implications for genomic organization. Nat Rev Genet. 2007, 8 (6): 413-423. 10.1038/nrg2083.View ArticlePubMed
- Ponting CP, Belgard TG: Transcribed dark matter: meaning or myth?. Hum Mol Genet. 2010, 19 (R2): R162-R168. 10.1093/hmg/ddq362.PubMed CentralView ArticlePubMed
- van Bakel H, Nislow C, Blencowe BJ, Hughes TR: Most “dark matter” transcripts are associated with known genes. PLoS Biol. 2010, 8 (5): e1000371-10.1371/journal.pbio.1000371.PubMed CentralView ArticlePubMed
- Faulkner GJ, Kimura Y, Daub CO, Wani S, Plessy C, Irvine KM, Schroder K, Cloonan N, Steptoe AL, Lassmann T, et al: The regulated retrotransposon transcriptome of mammalian cells. Nat Genet. 2009, 41 (5): 563-571. 10.1038/ng.368.View ArticlePubMed
- de Koning AP, Gu W, Castoe TA, Batzer MA, Pollock DD: Repetitive elements may comprise over two-thirds of the human genome. PLoS Genet. 2011, 7 (12): e1002384-10.1371/journal.pgen.1002384.PubMed CentralView ArticlePubMed
- Huang CR, Burns KH, Boeke JD: Active transposition in genomes. Annu Rev Genet. 2012, 46: 651-675. 10.1146/annurev-genet-110711-155616.PubMed CentralView ArticlePubMed
- Burns KH, Boeke JD: Human transposon tectonics. Cell. 2012, 149 (4): 740-752. 10.1016/j.cell.2012.04.019.PubMed CentralView ArticlePubMed
- Jurka J: Repbase update: a database and an electronic journal of repetitive elements. Trends Genet. 2000, 16 (9): 418-420. 10.1016/S0168-9525(00)02093-X.View ArticlePubMed
- Jurka J, Kapitonov VV, Pavlicek A, Klonowski P, Kohany O, Walichiewicz J: Repbase Update, a database of eukaryotic repetitive elements. Cytogenet Genome Res. 2005, 110 (1–4): 462-467.View ArticlePubMed
- O’Donnell KA, Burns KH, Boeke JD: A descent into the nuage: the maelstrom of transposon control. Dev Cell. 2008, 15 (2): 179-181. 10.1016/j.devcel.2008.07.016.PubMed CentralView ArticlePubMed
- Kaneko H, Dridi S, Tarallo V, Gelfand BD, Fowler BJ, Cho WG, Kleinman ME, Ponicsan SL, Hauswirth WW, Chiodo VA, et al: DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature. 2011, 471 (7338): 325-330. 10.1038/nature09830.PubMed CentralView ArticlePubMed
- Iskow RC, McCabe MT, Mills RE, Torene S, Pittard WS, Neuwald AF, Van Meir EG, Vertino PM, Devine SE: Natural mutagenesis of human genomes by endogenous retrotransposons. Cell. 2010, 141 (7): 1253-1261. 10.1016/j.cell.2010.05.020.PubMed CentralView ArticlePubMed
- Lee E, Iskow R, Yang L, Gokcumen O, Hanseley P, Luquette LJ, Lohr JG, Harris CC, Ding L, Wilson RK, et al: Landscape of somatic retrotransposition in human cancers. Science. 2012, 337 (6097): 967-971. 10.1126/science.1222077.PubMed CentralView ArticlePubMed
- Solyom S, Ewing AD, Rahrmann EP, Doucet T, Nelson HH, Burns MB, Harris RS, Sigmon DF, Casella A, Erlanger B, et al: Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res. 2012, 22 (12): 2328-2338. 10.1101/gr.145235.112.PubMed CentralView ArticlePubMed
- Sacha JB, Kim IJ, Chen L, Ullah JH, Goodwin DA, Simmons HA, Schenkman DI, von Pelchrzim F, Gifford RJ, Nimityongskul FA, et al: Vaccination with cancer- and HIV infection-associated endogenous retrotransposable elements is safe and immunogenic. J Immunol. 2012, 189 (3): 1467-1479. 10.4049/jimmunol.1200079.PubMed CentralView ArticlePubMed
- Roman-Gomez J, Jimenez-Velasco A, Agirre X, Cervantes F, Sanchez J, Garate L, Barrios M, Castillejo JA, Navarro G, Colomer D, et al: Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia. Oncogene. 2005, 24 (48): 7213-7223. 10.1038/sj.onc.1208866.View ArticlePubMed
- Weber B, Kimhi S, Howard G, Eden A, Lyko F: Demethylation of a LINE-1 antisense promoter in the cMet locus impairs Met signalling through induction of illegitimate transcription. Oncogene. 2010, 29 (43): 5775-5784. 10.1038/onc.2010.227.View ArticlePubMed
- Wolff EM, Byun HM, Han HF, Sharma S, Nichols PW, Siegmund KD, Yang AS, Jones PA, Liang G: Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet. 2010, 6 (4): e1000917-10.1371/journal.pgen.1000917.PubMed CentralView ArticlePubMed
- Frost RJ, Hamra FK, Richardson JA, Qi X, Bassel-Duby R, Olson EN: MOV10L1 is necessary for protection of spermatocytes against retrotransposons by Piwi-interacting RNAs. Proc Natl Acad Sci USA. 2010, 107 (26): 11847-11852. 10.1073/pnas.1007158107.PubMed CentralView ArticlePubMed
- Leeb M, Pasini D, Novatchkova M, Jaritz M, Helin K, Wutz A: Polycomb complexes act redundantly to repress genomic repeats and genes. Genes Dev. 2010, 24 (3): 265-276. 10.1101/gad.544410.PubMed CentralView ArticlePubMed
- Reichmann J, Crichton JH, Madej MJ, Taggart M, Gautier P, Garcia-Perez JL, Meehan RR, Adams IR: Microarray analysis of LTR retrotransposon silencing identifies Hdac1 as a regulator of retrotransposon expression in mouse embryonic stem cells. PLoS Comput Biol. 2012, 8 (4): e1002486-10.1371/journal.pcbi.1002486.PubMed CentralView ArticlePubMed
- Cleveland WS: Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc. 1979, 74: 829-836. 10.1080/01621459.1979.10481038.View Article
- Ihaka R, Gentleman R: R: a language for data analysis and graphics. J Comput Graph Stat. 1996, 5: 299-314.
- Smyth GK, Speed T: Normalization of cDNA microarray data. Methods. 2003, 31 (4): 265-273. 10.1016/S1046-2023(03)00155-5.View ArticlePubMed
- Beck CR, Collier P, Macfarlane C, Malig M, Kidd JM, Eichler EE, Badge RM, Moran JV: LINE-1 retrotransposition activity in human genomes. Cell. 2010, 141 (7): 1159-1170. 10.1016/j.cell.2010.05.021.PubMed CentralView ArticlePubMed
- Huang CR, Schneider AM, Lu Y, Niranjan T, Shen P, Robinson MA, Steranka JP, Valle D, Civin CI, Wang T, et al: Mobile interspersed repeats are major structural variants in the human genome. Cell. 2010, 141 (7): 1171-1182. 10.1016/j.cell.2010.05.026.PubMed CentralView ArticlePubMed
- Boissinot S, Chevret P, Furano AV: L1 (LINE-1) retrotransposon evolution and amplification in recent human history. Mol Biol Evol. 2000, 17 (6): 915-928. 10.1093/oxfordjournals.molbev.a026372.View ArticlePubMed
- Boissinot S, Entezam A, Young L, Munson PJ, Furano AV: The insertional history of an active family of L1 retrotransposons in humans. Genome Res. 2004, 14 (7): 1221-1231. 10.1101/gr.2326704.PubMed CentralView ArticlePubMed
- Belancio VP, Roy-Engel AM, Deininger P: The impact of multiple splice sites in human L1 elements. Gene. 2008, 411 (1–2): 38-45.PubMed CentralView ArticlePubMed
- Buzdin A, Ustyugova S, Gogvadze E, Vinogradova T, Lebedev Y, Sverdlov E: A new family of chimeric retrotranscripts formed by a full copy of U6 small nuclear RNA fused to the 3′ terminus of l1. Genomics. 2002, 80 (4): 402-406. 10.1006/geno.2002.6843.View ArticlePubMed
- Ostertag EM, Kazazian HH: Twin priming: a proposed mechanism for the creation of inversions in L1 retrotransposition. Genome Res. 2001, 11 (12): 2059-2065. 10.1101/gr.205701.PubMed CentralView ArticlePubMed
- Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, Fell HP, Ferree S, George RD, Grogan T, et al: Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol. 2008, 26 (3): 317-325. 10.1038/nbt1385.View ArticlePubMed
- Brawand D, Soumillon M, Necsulea A, Julien P, Csardi G, Harrigan P, Weier M, Liechti A, Aximu-Petri A, Kircher M, et al: The evolution of gene expression levels in mammalian organs. Nature. 2011, 478 (7369): 343-348. 10.1038/nature10532.View ArticlePubMed
- Speek M: Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol Cell Biol. 2001, 21 (6): 1973-1985. 10.1128/MCB.21.6.1973-1985.2001.PubMed CentralView ArticlePubMed
- Belancio VP, Roy-Engel AM, Pochampally RR, Deininger P: Somatic expression of LINE-1 elements in human tissues. Nucleic Acids Res. 2010, 38 (12): 3909-3922. 10.1093/nar/gkq132.PubMed CentralView ArticlePubMed
- Woodcock DM, Williamson MR, Doherty JP: A sensitive RNase protection assay to detect transcripts from potentially functional human endogenous L1 retrotransposons. Biochem Biophys Res Commun. 1996, 222 (2): 460-465. 10.1006/bbrc.1996.0766.View ArticlePubMed
- Muotri AR, Chu VT, Marchetto MC, Deng W, Moran JV, Gage FH: Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature. 2005, 435 (7044): 903-910. 10.1038/nature03663.View ArticlePubMed
- Rangwala SH, Zhang L, Kazazian HH: Many LINE1 elements contribute to the transcriptome of human somatic cells. Genome Biol. 2009, 10 (9): R100-10.1186/gb-2009-10-9-r100.PubMed CentralView ArticlePubMed
- Klattenhoff C, Theurkauf W: Biogenesis and germline functions of piRNAs. Development. 2008, 135 (1): 3-9.View ArticlePubMed
- Horard B, Eymery A, Fourel G, Vassetzky N, Puechberty J, Roizes G, Lebrigand K, Barbry P, Laugraud A, Gautier C, et al: Global analysis of DNA methylation and transcription of human repetitive sequences. Epigenetics. 2009, 4 (5): 339-350. 10.4161/epi.4.5.9284.View ArticlePubMed
- Gilson E, Horard B: Comprehensive DNA methylation profiling of human repetitive DNA elements using an MeDIP-on-RepArray assay. Methods Mol Biol. 2012, 859: 267-291. 10.1007/978-1-61779-603-6_16.View ArticlePubMed
- Sangaletti S, Stoppacciaro A, Guiducci C, Torrisi MR, Colombo MP: Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma. J Exp Med. 2003, 198 (10): 1475-1485. 10.1084/jem.20030202.PubMed CentralView ArticlePubMed
- An W, Dai L, Niewiadomska AM, Yetil A, O'Donnell KA, Han JS, Boeke JD: Characterization of a synthetic human LINE-1 retrotransposon ORFeus-Hs. Mob DNA. 2011, 14 (2(1)): 2-View Article
- Moran JV, Holmes SE, Naas TP, DeBerardinis RJ, Boeke JD, Kazazian HH: High frequency retrotransposition in cultured mammalian cells. Cell. 1996, 87 (5): 917-927. 10.1016/S0092-8674(00)81998-4.View ArticlePubMed
- Langmead B, Trapnell C, Pop M, Salzberg SL: Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009, 10 (3): R25-10.1186/gb-2009-10-3-r25.PubMed CentralView ArticlePubMed
- Jaffe AE, Feinberg AP, Irizarry RA, Leek JT: Significance analysis and statistical dissection of variably methylated regions. Biostatistics. 2011, 13 (1): 166-178.PubMed CentralView ArticlePubMed
- Jaffe AE, Murakami P, Lee H, Leek JT, Fallin MD, Feinberg AP, Irizarry RA: Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies. Int J Epidemiol. 2012, 41 (1): 200-209. 10.1093/ije/dyr238.PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.